A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.

NCT06079476 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Amgen